Literature DB >> 33512468

Dietary iron restriction improves markers of disease severity in murine sickle cell anemia.

Nermi L Parrow1, Pierre-Christian Violet2, Nisha Ajit George1, Faris Ali1, Shivam Bhanvadia1, Ryan Wong1, John F Tisdale3, Courtney Fitzhugh3, Mark Levine2, Swee Lay Thein4, Robert E Fleming1,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33512468      PMCID： PMC7976514          DOI： 10.1182/blood.2020006919

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   25.476


× No keyword cloud information.
  13 in total

1.  Regulation of serum hepcidin levels in sickle cell disease.

Authors:  Joyce J C Kroot; Coby M M Laarakkers; Erwin H J M Kemna; Bart J Biemond; Dorine W Swinkels
Journal:  Haematologica       Date:  2009-06       Impact factor: 9.941

2.  Sickle cell anemia a molecular disease.

Authors:  L PAULING; H A ITANO
Journal:  Science       Date:  1949-11-25       Impact factor: 47.728

3.  Intestine-specific Disruption of Hypoxia-inducible Factor (HIF)-2α Improves Anemia in Sickle Cell Disease.

Authors:  Nupur Das; Liwei Xie; Sadeesh K Ramakrishnan; Andrew Campbell; Stefano Rivella; Yatrik M Shah
Journal:  J Biol Chem       Date:  2015-08-19       Impact factor: 5.157

4.  Kinetics and mechanism of deoxyhemoglobin S gelation: a new approach to understanding sickle cell disease.

Authors:  J Hofrichter; P D Ross; W A Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

5.  Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload.

Authors:  Gloria C Preza; Piotr Ruchala; Rogelio Pinon; Emilio Ramos; Bo Qiao; Michael A Peralta; Shantanu Sharma; Alan Waring; Tomas Ganz; Elizabeta Nemeth
Journal:  J Clin Invest       Date:  2011-12       Impact factor: 14.808

6.  Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis.

Authors:  A J Duits; R C Pieters; A W Saleh; E van Rosmalen; H Katerberg; K Berend; R A Rojer
Journal:  Clin Immunol Immunopathol       Date:  1996-10

7.  Iron deficiency and sickle cell anemia.

Authors:  K R Rao; A R Patel; G R Honig; L N Vida; P R McGinnis
Journal:  Arch Intern Med       Date:  1983-05

8.  Improvement of sickle cell anemia by iron-limited erythropoiesis.

Authors:  O Castro; W N Poillon; H Finke; E Massac
Journal:  Am J Hematol       Date:  1994-10       Impact factor: 10.047

9.  Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.

Authors:  Minke A E Rab; Brigitte A van Oirschot; Jennifer Bos; Tesy H Merkx; Annet C W van Wesel; Osheiza Abdulmalik; Martin K Safo; Birgitta A Versluijs; Maite E Houwing; Marjon H Cnossen; Jurgen Riedl; Roger E G Schutgens; Gerard Pasterkamp; Marije Bartels; Eduard J van Beers; Richard van Wijk
Journal:  Am J Hematol       Date:  2019-03-08       Impact factor: 10.047

Review 10.  Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia.

Authors:  W Barcellini; B Fattizzo
Journal:  Dis Markers       Date:  2015-12-27       Impact factor: 3.434
View more
  1 in total

1.  Revisiting anemia in sickle cell disease and finding the balance with therapeutic approaches.

Authors:  Julia Zhe Xu; Swee Lay Thein
Journal:  Blood       Date:  2022-05-19       Impact factor: 25.476
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.